Box Layout

HTML Layout
Backgroud Images
Backgroud Pattern
  • E-mail : info_medicalmarketing@jindunmedical.com
  • Phone : +86 21 64057580
  • Address : Shanghai China

Gabapentin, epilepsy and headache together

  • 2022-10-09
  • JINDUN MEDICAL

Gabapentin is a new type of anti-epileptic drug that was launched in the UK in 1993 and has since been qualified for marketing in over 50 countries, and was also approved for produ

WEITERLESEN

Detection of 3-aminopiperidine in alogliptin benzoate by ion chromatography

  • 2022-10-09
  • JINDUN MEDICAL

Detection of 3-aminopiperidine in alogliptin benzoate by ion chromatography

WEITERLESEN

Affordable diabetes drug "Linagliptin" has a preventive effect on cardiovascular disease!

  • 2022-10-08
  • JINDUN MEDICAL

Obesity and type 2 diabetes are associated with the development of vascular sclerosis and cardiovascular disease.

WEITERLESEN

Scientists find unexpected "benefits" of diabetes drug Linagliptin

  • 2022-10-08
  • JINDUN MEDICAL

Recipes rich in fat and refined sugar have increased the number of obese and type 2 diabetics worldwide, and menopausal women with obesity and diabetes have a greater risk of heart

WEITERLESEN

Erythromycin status analysis, future market price can be expected!

  • 2022-10-08
  • JINDUN MEDICAL

Erythromycin is one of the bulk products exported from China's pharmaceutical raw materials, with a long-term export volume of thousands of tons and hundreds of millions of dol

WEITERLESEN

How do I take azithromycin correctly?

  • 2022-10-08
  • JINDUN MEDICAL

The mechanism of action of Azithromycin is similar to Erythromycin.

WEITERLESEN

Recommend-Acetoxy Empagliflozin-Manufacturer

  • 2022-10-08
  • JINDUN MEDICAL

Acetoxy Empagliflozin is an intermediate for the synthesis of Empagliflozin. Empagliflozin, a sodium glucose cotransporter (SGLT2) inhibitor developed by Boehringer Ingelheim and L

WEITERLESEN

Recommend-Empagliflozin-Manufacturer

  • 2022-10-08
  • JINDUN MEDICAL

Empagliflozin is hypoglycemic drugs. Sodium glucose cotransporter 2 (SGLT-2) is a major transporter that reabsorbes glucose from glomerular filtrate into blood circulation.

WEITERLESEN

Recommend-Sitagliptin base-Manufacturer

  • 2022-10-08
  • JINDUN MEDICAL

Sitagliptin is a new anti type II diabetes drug approved by FDA and the first dipeptidyl peptidase IV inhibitor used to treat type II diabetes.

WEITERLESEN

US p-nitrobenzoic acid import customs clearance operation process

  • 2022-10-08
  • JINDUN MEDICAL

P-nitrobenzoic acid belongs to chemical goods, simple introduction of customs clearance process

WEITERLESEN